Huadong Medicine Co., Ltd

000963.SZ · Shenzhen Stock Exchange · CNY

26,87CNY

−0,18 (−0,67 %)Stand 10. Nov., 7:04

Vortag 27,05

Kennzahlen

Eröffnung
27,05
Vortag
27,05
Tagesspanne
26,82 – 27,19
52 Wochen
25,63 – 43,78
Volumen
11,06 Mio.
Ø Volumen
21,49 Mio.
Börsenwert
47,12 Mrd. CNY
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
0,0
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.

CEO
Liang Lv
Mitarbeitende
19.095
Hauptsitz
Hangzhou, ZH, CN
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
27. Jan. 2000

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.